The burden of central line-associated bloodstream infections in children with medical complexity

被引:2
|
作者
Scarselli, Alessia [1 ]
Smarrazzo, Andrea [1 ]
De Sanctis, Francesco [1 ]
Rava, Lucilla [1 ]
Carletti, Michaela [1 ]
Ciofi Degli Atti, Marta [1 ]
Aversa, Marcella [1 ]
Drago, Riccardo [1 ]
Crocoli, Alessandro [1 ]
Geremia, Caterina [1 ]
Guerricchio, Andrea [1 ]
Lucignano, Barbara [1 ]
Campana, Andrea [1 ]
De Ioris, Maria Antonietta [1 ]
Perrotta, Daniela [1 ]
机构
[1] Bambino Gesu Pediat Hosp, Rome, Italy
来源
JOURNAL OF VASCULAR ACCESS | 2023年 / 24卷 / 02期
关键词
CLABSI; children; pediatric intensive care unit; children with medical complexity; gastrostomy; jejunostomy; tracheostomy; BACTERIAL TRANSLOCATION; VENOUS ACCESS; CARE; RISK; DEFINITIONS; DIAGNOSIS;
D O I
10.1177/11297298211027468
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Central line-associated bloodstream infections (CLABSI) are significant cause of complications in pediatric intensive care units (PICUs). An emerging challenge are CLABSIs in children with medical complexity (CMC) admitted to PICU. CMC are patients with chronic conditions with or without neurological impairment needing for tracheostomy and/or home mechanical or non-invasive ventilation and/or gastrostomy/jejunostomy. We evaluate CLABSI incidence in a PICU with high prevalence of CMC. Methods: This was a retrospective study in the PICU of the Bambino Gesu Children Hospital from January 2017 to December 2020. The medical records were reviewed and demographic, clinical and microbiological data were extracted. CLABSI were defined according to the Center for Disease Control and Prevention's National Healthcare Safety Networks (NHSN) surveillance. Results: A total of 101 children with 125 central lines (CLs) were included; 79/101 (78%) patients were CMC and 50/101 (50%) had a thracheostomy. CLABSI incidence was 2.75/1000 CL-days (9 cases/3269 CL-days); incidence was 0 in patients without underling conditions and 3.14/1000 in CMC (p < 0.001). CLABSI were due to gram negative bacteria in five patients, Candida spp in three and Staphylococcus hominis in one. CLs were removed in eight cases while in the later one, with CLABSI due to Pseudomonas aeruginosa, a conservative strategy was adopted cause of unavailable alternative venous access and removed at discharge with negative culture. All patients recovered. Conclusions: A target 0% CLABSI was possible in critically ill children without underling condition while a high incidence was reported in CMC and sustained by a peculiar CLABSI ecology. This ecology should be considered when a CLABSI was suspected in CMC for prompt antibiotics stewardship.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 50 条
  • [11] Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children
    Jitrungruengnij, Nattapong
    Anugulruengkitt, Suvaporn
    Rattananupong, Thanapoom
    Prinyawat, Mayuree
    Jantarabenjakul, Watsamon
    Wacharachaisurapol, Noppadol
    Chatsuwan, Tanittha
    Janewongwirot, Pakpoom
    Suchartlikitwong, Pintip
    Tawan, Monta
    Kanchanabutr, Phavinee
    Pancharoen, Chitsanu
    Puthanakit, Thanyawee
    PEDIATRICS INTERNATIONAL, 2020, 62 (07) : 789 - 796
  • [12] Central Line-Associated Bloodstream Infections: Prevention and Management
    Weber, David J.
    Rutala, William A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2011, 25 (01) : 77 - +
  • [13] Central Line-Associated Bloodstream Infections: Evidence for Practice
    DePalma, Judith A.
    HOME HEALTH CARE MANAGEMENT AND PRACTICE, 2010, 22 (04): : 294 - 296
  • [14] Reduction of Central Line-Associated Bloodstream Infections in the NICU
    Cooley, Kim
    Samaniego-Yamin, Lourdes
    Wershing, Marianne
    Cook, Linda
    Croft, Valerie
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2019, 48 (03): : S92 - S93
  • [15] Probabilistic Measurement of Central Line-Associated Bloodstream Infections
    Hota, Bala
    Malpiedi, Paul
    Fridkin, Scott K.
    Martin, John
    Trick, William
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (02): : 149 - 155
  • [16] Moving Beyond Central Line-Associated Bloodstream Infections
    Howard-Anderson, Jessica
    Morgan, Daniel J.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 822 - 823
  • [17] Pediatric Ambulatory Central Line-Associated Bloodstream Infections
    Rinke, Michael L.
    Heo, Moonseong
    Saiman, Lisa
    Bundy, David G.
    Rosenberg, Rebecca E.
    DeLaMora, Patricia
    Rabin, Barbara
    Zachariah, Philip
    Mirhaji, Parsa
    Ford, William J. H.
    Obaro-Best, Oghale
    Drasher, Michael
    Klein, Elizabeth
    Peshansky, Alexandre
    Oyeku, Suzette O.
    PEDIATRICS, 2021, 147 (01)
  • [18] Diagnosing and Reporting of Central Line-Associated Bloodstream Infections
    Beekmann, Susan E.
    Diekema, Daniel J.
    Huskins, W. Charles
    Herwaldt, Loreen
    Boyce, John M.
    Sherertz, Robert J.
    Polgreen, Philip M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (09): : 875 - 882
  • [19] Prevention of Central Line-Associated Bloodstream Infections in Children: Current Challenges and Opportunities
    Whalen A.
    Mack E.H.
    Current Treatment Options in Pediatrics, 2020, 6 (3) : 203 - 213
  • [20] Effect of Central Line Bundle Compliance on Central Line-Associated Bloodstream Infections
    Lee, Kyoung Hwa
    Cho, Nan Hyoung
    Jeong, Su Jin
    Kim, Mi Na
    Han, Sang Hoon
    Song, Young Goo
    YONSEI MEDICAL JOURNAL, 2018, 59 (03) : 376 - 382